Company profile: Sarissa Biomedical
1.1 - Company Overview
Company description
- Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
Products and services
- Microelectrode Electrochemical Sensors: Minimally invasive devices that quantify purines and other neurochemicals in blood, delivering rapid, accurate diagnostic readouts for neurological activity and disorders
- Electrochemical Biosensors: Blood-based devices that detect metabolic changes by measuring neurochemicals like serotonin and dopamine, aiding diagnosis and monitoring of neurological disorders
- Product Design Platform: Microelectrode architecture delivering exquisite sensitivity, broad linear range, and high accuracy to underpin development of minimally invasive electrochemical sensors for purines and other neurochemicals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sarissa Biomedical
Mologic
HQ: United Kingdom
Website
- Description: Provider of point-of-care diagnostic solutions, offering contract research for assay and antibody development, flexible manufacturing of lateral flow diagnostics, and a portfolio of rapid tests for health issues including yellow fever and chronic obstructive pulmonary disorder. Also partners with governments and organizations to distribute diagnostics globally, focusing on areas with significant need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mologic company profile →
Primity Bio
HQ: United States
Website
- Description: Provider of biomarker and immune monitoring services, offering innovative flow cytometry platforms to biopharma for use throughout the drug discovery process, from lead selection to clinical trial sample analysis, with specialized discovery platforms for profiling cell surface and intracellular signaling proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primity Bio company profile →
Immunicom
HQ: United States
Website
- Description: Provider of patented Immunopheresis blood-filtering technology that removes specific blood factors to enable the immune system to fight certain cancers; the LW-02 investigational therapeutic cartridge; the EN-06 cartridge in pre-clinical development; and clinical trials at leading hospitals evaluating LW-02 for triple-negative breast cancer, non-small cell lung cancer, melanoma, and renal cell carcinoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunicom company profile →
Cellix
HQ: Ireland
Website
- Description: Provider of microfluidic pumping solutions, consumable biochips, software, and automated solutions for cell biology, microfluidics and nanofluidics, physics, chemistry, and cell and particle studies. Offerings include pulse-free syringe, pressure and recirculating pumps with PC control, VenaFlux for shear flow assays, the Inish Analyser for label-free cell counting, viability and transfection efficiencies, and disposable biochips for flow and droplet studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellix company profile →
Guava Technologies
HQ: United States
Website
- Description: Provider of biotechnology and medical devices, including unique flow cytometry and benchtop cell analysis systems. Offers HIV/AIDS monitoring, viacount cell counting and viability assays, antibody quantification, apoptosis assay suite, cell cycle, cytotoxicity, and cell proliferation assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guava Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sarissa Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sarissa Biomedical
2.2 - Growth funds investing in similar companies to Sarissa Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sarissa Biomedical
4.2 - Public trading comparable groups for Sarissa Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →